首页> 外文OA文献 >Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma

【2h】

Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma

机译：通过新型疾病受体7/8激动剂3M-007和干扰素-γ的细胞免疫应答的协同增强：对皮肤T细胞淋巴瘤的治疗的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Maria Wysocka; Noor Dawany; Bernice Benoit; Andrew V. Kossenkov; Andrea B. Troxel; Joel M. Gelfand; Michael kelly Sell; Louise C. Showe; Alain H. Rook;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-gamma: implications for therapy of cutaneous T-cell lymphoma. [J] . Wysocka M, Dawany N, Benoit B, Leukemia and lymphoma . 2011,第10期

机译：新型Toll受体7/8激动剂3M-007和干扰素-γ协同增强细胞免疫反应：对皮肤T细胞淋巴瘤的治疗意义。
2. Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma [J] . HuenA.O., RookA.H. Current Opinion in Oncology . 2014,第2期

机译：Toll受体激动剂治疗皮肤癌和皮肤T细胞淋巴瘤
3. A BRAF inhibitor and a Toll-like receptor 7 agonist synergistically enhanced anti-tumor immune responses [J] . Nakamura K., Yaguchi T., Murata M., The Journal of investigative dermatology. . 2017,第5期

机译：BRAF抑制剂和Toll样受体7激动剂协同增强的抗肿瘤免疫应答
4. Photodynamic therapy stimulates anti-tumor immune response in mouse models: the role of regulatory T-cells, anti-tumor antibodies, and immune attack on brain metastases [C] . Fatma Vatansever, Masayoshi Kawakubo, Hoon Chung, Biophotonics and immune responses VIII . 2013

机译：光动力疗法在小鼠模型中刺激抗肿瘤免疫反应：调节性T细胞，抗肿瘤抗体的作用以及对脑转移瘤的免疫攻击
5. Natural Toll-like receptor agonists in prophylactic vaccines for in situ vaccination lymphoma immunotherapy. [D] . Peng, Paul. 2016

机译：预防性疫苗中的天然Toll样受体激动剂，用于原位接种淋巴瘤免疫治疗。
6. Synergistic Enhancement of Cellular Immune Responses by the Novel Toll Receptor 7/8 Agonist 3M 007 and Interferon-γ: Implications for Therapy of Cutaneous T-Cell Lymphoma [O] . Maria Wysocka, Noor Dawany, Bernice Benoit, -1

机译：新型疾病受体7/8激动剂3M 007和干扰素-γ的细胞免疫应答的协同增强：对皮肤T细胞淋巴瘤治疗的影响
7. 772 A BRAF inhibitor and a Toll-like receptor 7 agonist synergistically enhanced anti-tumor immune responses [O] . K. Nakamura, T. Yaguchi, M. Murata, 2017

机译：772 BRAF抑制剂和Toll样受体7激动剂协同增强的抗肿瘤免疫应答

Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma

著录项

引文网络

相似文献

相关主题

期刊订阅